| |||||||||||||||
| These RenTgMK mice may be useful in studying the effects of genetically clamped renin (and angiotensin II) on hypertension, diabetic nephropathy, albuninurea, nephrosclerosis, and other aspects of the renin–angiotensin system (RAS). | |||||||||||||||
Type Mutant Strain; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Noncarrier x Hemizygote (Female x Male) Species laboratory mouse Generation N12+F Donating Investigator Thomas Coffman, Duke University Medical Center (AMDCC) Description
Mice heterozygous for the RenTgMK transgene are viable and fertile. The RenTgMK transgene contains a liver-specific albumin promoter/enhancer controlling the expression of a synthetic renin gene (engineered to allow efficient cleavage and secretion of the prorenin transgene product by the liver). This, and because the transgene was targeted to the apolipoprotein locus on Chromosome 9, results in active renin secretion from the liver independently of renal or other homeostatic cardiovascular control mechanisms (i.e. genetically clamped). RenTgMK heterozygotes have high ectopic levels of active mouse renin in the liver and elevated plasma levels of prorenin and active renin. Heterozygous mice display significantly elevated blood pressure, enhanced thirst, high urine output, proteinuria, and kidney damage. Because active renin overexpression results in increased circulating levels of angiotensin II (Ang II), heterozygotes also exhibit cardiac hypertrophy and 50% male mortality between 6-8 months of age. These RenTgMK mice may be useful in studying the effects of genetically clamped renin (and angiotensin II) on hypertension, diabetic nephropathy, albuninurea, nephrosclerosis, and other aspects of the renin?angiotensin system (RAS).Development
A targeting construct was designed to insert a single copy of the RenTgMK transgene into the apolipoprotein locus between the Apoa1 and Apoc3 genes on Chromosome 9. The RenTgMK transgene contains (from 5' to 3') a neomycin resistance cassette, a liver-specific mouse albumin promoter/enhancer sequence (with a 20-bp oligonucleotide insert in the 5' untranslated region (UTR) to increase its length), a synthetic mouse renin cDNA (with a c-myc epitope tag at the 3' end), and a rabbit beta-globin 3' UTR. The synthetic renin cDNA is designed with portions of the Ren-2 (Ren2) and Ren-1d (Ren1) genes to allow efficient processing from prorenin to renin in hepatic or other cells by the ubiquitous enzyme furin. The targeting construct was introduced into 129S6/SvEvTac-derived TC-1 embryonic stem (ES) cells. The donating investigator reports that chimeric males were bred to "129SvEv" females and then maintained on a 129S6/SvEvTac background by Dr. Oliver Smithies and Dr. Nobuyo N. Maeda (University of North Carolina). In 2002, these RenTgMK were sent to Thomas M. Coffman (Duke University) and then backcrossed to 129S6/SvEvTac for at least 11 generations prior to arrival at The Jackson Laboratory.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Alb
000186 B6.Cg-Albc/J 007238 B6.Cg-Tg(Alb-PLG)1Dgi/J 007244 B6;SJL-Tg(Alb-F5)2Dgi/J 007245 B6;SJL-Tg(Alb-F5)3Dgi/J 002226 C57BL/6J-Tg(Alb1HBV)44Bri/J View Strains carrying other alleles of Alb (5 strains)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Tg(Alb1-Ren)1Unc/?
129S6/SvEvTac-Tg(Alb1-Ren)1Unc
- cardiovascular system phenotype
- increased blood pressure (MGI Ref ID J:125933)
- 145+/-8 mmHg compared to 108+/-9 mmHg in wild-type mice
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Tg(Alb1-Ren)1Unc/0
involves: 129S6/SvEvTac * C57BL/6
- life span-post-weaning/aging
- premature death (MGI Ref ID J:88650)
- about 60% of transgenic males die suddenly between 6 and 8 months of age
- behavior/neurological phenotype
- polydipsia (MGI Ref ID J:89252)
- transgenic mice drink significantly more than non-transgenic mice
- cardiovascular system phenotype
- cardiac hypertrophy (MGI Ref ID J:88650)
- transgenic mice have: increased left ventricle/body weight ratios; increased cardiac myocyte cross-sectional area; generalized fibrosis; decreased left ventricular end systolic dimension coupled with increased cardiac function, indicating that these mice have concentric hypertrophy, without ventricular dilation or overt heart failure
- decreased heart rate (MGI Ref ID J:88650)
- in mice that die prematurely a prolonged and progressive bradycardia is seen
- transgenics show a significant decrease in heart rate variability compared to wild-type mice
- hypertension (MGI Ref ID J:89252)
- transgenic mice have blood pressures more than 25 mmHg higher than wild-type mice
- administration of an angiotensin II receptor antagonist lowered blood pressure in transgenic mice down to that seen in wild-type mice
- transgenic mice have blood pressures more than 25 mmHg higher than wild-type mice
- homeostasis/metabolism phenotype
- albuminuria (MGI Ref ID J:89252)
- urine protein/creatinine ratios are elevated and an increase in albumin in the urine of transgenic mice is seen
- administration of an angiotensin II receptor antagonist improved this condition
- decreased urine osmolality (MGI Ref ID J:89252)
- transgenic mice produce dilute urine but are able to produce concentrated urine following water deprivation
- increased circulating creatinine level (MGI Ref ID J:89252)
- serum creatinine is elevated in transgenic mice
- immune system phenotype
- kidney inflammation (MGI Ref ID J:89252)
- vascular, glomerular, and tubointerstitial changes indicative of hypertensive nephrosclerosis are seen in transgenic mice
- cortical sections show inflammatory infiltrates, fibroid necrosis and arterial disruption
- administration of an angiotensin II receptor antagonist ameliorated these pathological changes
- renal/urinary system phenotype
- albuminuria (MGI Ref ID J:89252)
- urine protein/creatinine ratios are elevated and an increase in albumin in the urine of transgenic mice is seen
- administration of an angiotensin II receptor antagonist improved this condition
- decreased urine osmolality (MGI Ref ID J:89252)
- transgenic mice produce dilute urine but are able to produce concentrated urine following water deprivation
- kidney inflammation (MGI Ref ID J:89252)
- vascular, glomerular, and tubointerstitial changes indicative of hypertensive nephrosclerosis are seen in transgenic mice
- cortical sections show inflammatory infiltrates, fibroid necrosis and arterial disruption
- administration of an angiotensin II receptor antagonist ameliorated these pathological changes
- polyuria (MGI Ref ID J:89252)
| Allele Symbol | Tg(Alb1-Ren)1Unc | ||
|---|---|---|---|
| Allele Name | transgene insertion 1, University of North Carolina | ||
| Allele Type | Targeted (other) | ||
| Common Name(s) | RenTg; RenTgMK; Tg(Alb1-Ren)1Smi; | ||
| Mutation Made By | Oliver Smithies, University of North Carolina | ||
| Strain of Origin | 129S6/SvEvTac | ||
| ES Cell Line Name | TC-1 | ||
| ES Cell Line Strain | 129S6/SvEvTac | ||
| Expressed Gene | Ren1, renin 1 structural, mouse, laboratory | ||
| Promoter | Alb, albumin, mouse, laboratory | ||
| Molecular Note | A single copy of a transgene consisting of a liver specific albumin promoter, a 20 bp insert in the 5' UTR to increase length, a synthetic mouse renin cDNA, and a rabbit beta-globin 3' UTR was inserted into the apolipoprotein locus between the Apoa1 and Apoc3 genes. [MGI Ref ID J:89252] | ||
| Gene Symbol and Name | Tg(Alb1-Ren)1Unc, transgene insertion 1, University of North Carolina | ||
| Chromosome | UN | ||
Genotyping Protocols
Tg(Alb1-Ren)1Unc, STD PCR, vers. 1
Helpful Links
Genotyping resources and troubleshooting
Caron KM; James LR; Kim HS; Knowles J; Uhlir R; Mao L; Hagaman JR; Cascio W; Rockman H; Smithies O. 2004. Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc Natl Acad Sci U S A 101(9):3106-11. [PubMed: 14978280] [MGI Ref ID J:88650]
Caron KM; James LR; Kim HS; Morham SG; Sequeira Lopez ML; Gomez RA; Reudelhuber TL; Smithies O. 2002. A genetically clamped renin transgene for the induction of hypertension. Proc Natl Acad Sci U S A 99(12):8248-52. [PubMed: 12034874] [MGI Ref ID J:89252]
Tg(Alb1-Ren)1Unc relatedCaron K; Hagaman J; Nishikimi T; Kim HS; Smithies O. 2007. Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males. Proc Natl Acad Sci U S A 104(9):3420-5. [PubMed: 17360661] [MGI Ref ID J:125933]
Caron KM; James LR; Lee G; Kim HS; Smithies O. 2005. Lifelong genetic minipumps. Physiol Genomics 20(2):203-9. [PubMed: 15585607] [MGI Ref ID J:95789]
Pandya K; Kim HS; Smithies O. 2006. Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo. Proc Natl Acad Sci U S A 103(45):16864-9. [PubMed: 17068123] [MGI Ref ID J:132484]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, hemizygous (heterozygous) mice can be bred with wildtype littermates. Mating System Noncarrier x Hemizygote (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $243.50 Female or Male Hemizygous for Tg(Alb1-Ren)1Unc
Pairs /Price (US dollars $) Pair Genotype $297.85 Hemizygous for Tg(Alb1-Ren)1Unc x Noncarrier $297.85 Noncarrier x Hemizygous for Tg(Alb1-Ren)1Unc
| Pricing for International shipping destinations |
|
Weeks of Age Price (US dollars $) Gender Genotypes Provided Individual Mouse $316.60 Female or Male Hemizygous for Tg(Alb1-Ren)1Unc
Pairs /Price (US dollars $) Pair Genotype $387.30 Hemizygous for Tg(Alb1-Ren)1Unc x Noncarrier $387.30 Noncarrier x Hemizygous for Tg(Alb1-Ren)1Unc
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within two business days following order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.